Olopatadine Hydrochloride Ophthalmic Solution Solution/ Drops
NDC Package 11673-689-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Olopatadine Hydrochloride Ophthalmic Solution solution/ dropses is • adults and children 2 years of age and older: • put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per day • if using other ophthalmic products while using this product, wait at least 5 minutes between each product • replace cap after each use   • children under 2 years of age: consult a doctor. This formulation utilizes a solution/ drops delivery system. Marketed by Target Corporation, this product is identified by NDC 11673-689 and is authorized under FDA application ANDA209619.

Identification & Billing

NDC Package Code
11673-689-05
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 5 mL in 1 BOTTLE, PLASTIC
Product Code
11673-689
11-Digit Billing Format
11673068905
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Olopatadine Hydrochloride Ophthalmic Solution
Non-Proprietary Name
Olopatadine Hydrochloride Ophthalmic Solution
Substance Name
Olopatadine Hydrochloride
Dosage Form
Solution/ Drops - A solution which is usually administered in a drop-wise fashion.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
OLOPATADINE HYDROCHLORIDE 1 mg/mL
Pharmacologic Class
Usage Information
• adults and children 2 years of age and older: • put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per day • if using other ophthalmic products while using this product, wait at least 5 minutes between each product • replace cap after each use   • children under 2 years of age: consult a doctor

Regulatory & Marketing

Labeler Name
Target Corporation
Product Type
Human Otc Drug
FDA Application #
ANDA209619
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-22-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 11673-689-05 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 5 ml in 1 bottle, plastic of Olopatadine Hydrochloride Ophthalmic Solution, a human over the counter drug labeled by Target Corporation. This solution/ drops is formulated for ophthalmic use and contains olopatadine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Target Corporation on October 22, 2021. The current certification is valid through December 31, 2026.

How is this Target Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 11673068905. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
11673-689-05
11-Digit CMS (5-4-2)
11673-0689-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.